Search
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 1 - 15 of 24 items.
Health Canada is updating the labels of the Janssen and Vaxzevria (AstraZeneca) COVID-19 vaccines
AlertPublic advisory | 2021-11-09
AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak Syndrome
AlertHealth professional risk communication | 2021-06-29
AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Thrombosis with Thrombocytopenia
AlertHealth professional risk communication | 2021-03-24
Authorization of AstraZeneca COVID-19 Vaccine with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2021-03-01
Importation of AstraZeneca COVID-19 Vaccine with English-only Vial and Carton Labels (US-Labelled Supply)
AlertHealth professional risk communication | 2021-03-31
Archived – Important Safety Information Regarding Accolate® (Zafirlukast) and Hepatic Effects – AstraZeneca
AlertHealth professional risk communication | 2002-12-18
Important Safety Information on Oxeze (formoterol fumarate dihydrate) Turbuhaler – AstraZeneca Canada Inc. – For Health Professionals
AlertHealth professional risk communication | 2005-09-09
Association of CRESTOR® (rosuvastatin) with Muscle -Related Adverse Events – AstraZeneca Canada Inc. – For Health Professionals
AlertHealth professional risk communication | 2005-03-11
Archived – Important Safety Information Concerning Liver Problems for Patients Taking ACCOLATE® (Zafirlukast) – AstraZeneca Canada Inc. – For the Public
AlertHealth professional risk communication | 2004-04-19
Archived – Health Canada advises to stop using AstraZeneca Xylocaine 2% Jelly Single Use Plastic Syringes due to potential health risks
AlertPublic advisory | 2006-09-27
Archived – Important Safety Information Regarding Medication Errors Resulting From Confusion Between Seroquel and Serzone-5HT2 – AstraZeneca and Bristol-Myers Squibb – For the Public
AlertHealth professional risk communication | 2002-10-31
Archived – Important Safety Information Regarding Medication Errors Resulting from Confusion Between Seroquel® and Serzone-5HT2® – AstraZeneca and Bristol-Myers Squibb
AlertHealth professional risk communication | 2002-10-31
Pulmicort Nebuamp - (0.125 mg/mL, 0.25 mg/mL, 0.5 mg/mL)
RecallHealth product recall | 2013-02-18
Archived – Important Safety Information Regarding the Association Between CRESTOR (Rosuvastatin) and Rhabdomyolysis
AlertHealth professional risk communication | 2004-06-22
Archived – Important Safety Information Regarding Casodex 150 mg – Accelerated Deaths in Localized Prostate Cancer Patients – For the Public
AlertHealth professional risk communication | 2003-08-26